P/E at 65.2 vs Industry's 60.64: What the Data Shows for Max Healthcare Institute Ltd

Valuation Picture: Premium Above Industry Average

The current P/E of Max Healthcare Institute Ltd stands at 65.20, which is approximately 7.6% higher than the hospital industry’s average P/E of 60.64. This premium suggests that investors are pricing in expectations of stronger earnings growth or superior operational performance relative to peers. However, the elevated valuation also increases the risk of a sharper correction should earnings disappoint or sector headwinds intensify. The market cap of Rs 96,881.55 crores places the company firmly in the large-cap category, which typically commands a valuation premium due to perceived stability and liquidity.

Given this valuation context, Max Healthcare Institute Ltd’s premium raises the question — previously rated Hold, what is Max Healthcare’s current rating? The four-parameter analysis factors in the valuation premium alongside performance and technical indicators.

Performance Across Timeframes: Divergent Momentum

Examining returns over multiple periods reveals a mixed performance profile. Over the past year, Max Healthcare Institute Ltd has declined by 14.28%, underperforming the Sensex’s 6.80% fall by a wide margin. This underperformance is echoed in the one-week and three-month returns, where the stock fell 7.51% and 8.82% respectively, compared with the Sensex’s modest gains and smaller declines over the same periods.

However, the year-to-date return of -4.73% is notably better than the Sensex’s -10.81%, indicating some recovery or resilience in recent months. The one-month return of -1.45% also slightly outperforms the Sensex’s -1.68%. This divergence between short-term and longer-term returns suggests that while the stock has struggled over the past year, recent price action may be stabilising — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Moving Average Configuration: Bearish Technical Setup

The technical picture for Max Healthcare Institute Ltd remains challenging. The stock is trading below all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This alignment typically signals a sustained downtrend, with no immediate technical support from short or long-term averages. The fact that the stock has gained after three consecutive days of decline is a short-term positive, but the broader trend remains bearish.

Trading below all major moving averages often indicates that the stock is in a recovery phase within a larger downtrend, rather than a confirmed uptrend. This technical setup raises the question — is this a dead-cat bounce or the start of a sustained turnaround?

Sector Context: Hospital Industry Performance

The hospital sector, within which Max Healthcare Institute Ltd operates, has experienced mixed results recently. While the industry P/E stands at 60.64, reflecting moderate valuation levels, sector returns have varied widely among constituents. The sector’s performance has been weighed down by regulatory pressures and rising operational costs, factors that have contributed to the underperformance of several large-cap hospital stocks.

Within this environment, Max Healthcare Institute Ltd’s sharper decline relative to the Sensex and its peers highlights company-specific challenges or market sentiment factors. The sector’s mixed results prompt the question — should investors in Max Healthcare hold, buy more, or reconsider?

Rating Context: Previous Hold, Now Reassessed

MarketsMOJO had previously rated Max Healthcare Institute Ltd as Hold. The rating was updated on 31 Oct 2025, reflecting changes in the company’s valuation, performance, and technical outlook. The current Mojo Score stands at 42.0, with a Mojo Grade of Sell, indicating a shift in the assessment framework. This reassessment aligns with the stock’s underperformance over the past year and its technical weakness, despite the valuation premium.

Such a rating change invites scrutiny of the underlying data — what does the current rating imply for investors navigating this complex landscape?

Long-Term Performance: Strong Historical Gains

Despite recent setbacks, Max Healthcare Institute Ltd has delivered impressive returns over longer horizons. The three-year return stands at 84.45%, significantly outperforming the Sensex’s 21.61% over the same period. Even more striking is the five-year return of 330.65%, dwarfing the Sensex’s 48.70%. These figures underscore the company’s capacity for substantial value creation over time, though recent performance has not followed this trend.

This contrast between long-term outperformance and short-term weakness raises a critical question — is the current weakness a temporary setback or a sign of structural change?

Intraday and Recent Price Action

On 27 May 2026, Max Healthcare Institute Ltd opened at ₹998.3 and traded at this level throughout the day, closing with a modest gain of 0.18%, outperforming the sector by 0.51%. This gain followed three consecutive days of decline, suggesting a potential short-term pause in selling pressure. However, the stock remains below all major moving averages, reinforcing the cautious technical outlook.

Collective Data Insights

Bringing together valuation, performance, technical, and rating data paints a nuanced picture for Max Healthcare Institute Ltd. The stock trades at a premium valuation relative to its industry, reflecting expectations of superior earnings or growth. Yet, its recent underperformance against the Sensex and sector peers, combined with a bearish moving average configuration, signals caution. The rating reassessment from Hold to a lower grade further emphasises this tension between valuation and performance.

Investors must weigh these factors carefully — should Max Healthcare remain in portfolios, or is it time to explore alternatives?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →